These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19276996)

  • 1. Tapering versus cold turkey: symptoms versus successful discontinuation of menopausal hormone therapy.
    Suffoletto JA; Hess R
    Menopause; 2009; 16(3):436-7. PubMed ID: 19276996
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
    Haskell SG; Bean-Mayberry B; Gordon K
    Menopause; 2009; 16(3):494-9. PubMed ID: 19182695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How best is to discontinue postmenopausal hormone therapy: immediate or tapered?
    Aslan E; Bagis T; Kilicdag EB; Tarim E; Erkanli S; Kuscu E
    Maturitas; 2007 Jan; 56(1):78-83. PubMed ID: 17046182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 5. Guidelines for hormone treatment of women in the menopausal transition and beyond.
    Naftolin F; Schneider HP; Sturdee DW;
    Maturitas; 2005 May; 51(1):15-20. PubMed ID: 15883104
    [No Abstract]   [Full Text] [Related]  

  • 6. Different menopausal hormone regimens and risk of breast cancer.
    Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
    Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement therapy and asthma.
    Ticconi C; Pietropolli A; Piccione E
    Pulm Pharmacol Ther; 2013 Dec; 26(6):617-23. PubMed ID: 24035822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women.
    Simon J; Klaiber E; Wiita B; Bowen A; Yang HM
    Menopause; 1999; 6(2):138-46. PubMed ID: 10374221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary artery disease and menopausal hormone therapy].
    Mizia-Stec K; Zahorska-Markiewicz B; Gasior Z; Holecki M
    Pol Arch Med Wewn; 2004 Oct; 112(4):1255-63. PubMed ID: 15773440
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer and hormone-replacement therapy: the Million Women Study.
    Garton M
    Lancet; 2003 Oct; 362(9392):1328; author reply 1330-1. PubMed ID: 14575985
    [No Abstract]   [Full Text] [Related]  

  • 11. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
    Dew JE; Wren BG; Eden JA
    Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical perspectives in postmenopausal hormone therapy: defining the right dose and duration.
    Warren MP
    Mayo Clin Proc; 2007 Feb; 82(2):219-26. PubMed ID: 17290731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone therapy for vasomotor symptoms: balancing the risks and benefits with ultra-low doses of estrogen.
    Simon JA; Snabes MC
    Expert Opin Investig Drugs; 2007 Dec; 16(12):2005-20. PubMed ID: 18042008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a time limit for systemic menopausal hormone therapy?
    Lipold LD; Batur P; Kagan R
    Cleve Clin J Med; 2016 Aug; 83(8):605-12. PubMed ID: 27505882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence based basis of decision making for or against a postmenopausal hormone treatment].
    Rásky E
    Wien Klin Wochenschr; 2004 Jul; 116(14):461-4; discussion 504. PubMed ID: 15379140
    [No Abstract]   [Full Text] [Related]  

  • 17. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 18. Addendum: Transdermal estrogen (Med Lett Drugs Ther 2012;54:41).
    Med Lett Drugs Ther; 2012 Jul; 54(1394):56. PubMed ID: 22826825
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcutaneous hormone replacement therapy.
    Tzingounis VA; Perdikaris AG; Lioutas G; Dimopoulos D
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):64-6. PubMed ID: 8365523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormones and risk of ovarian cancer.
    Moorman PG; Schildkraut JM; Calingaert B; Halabi S; Berchuck A
    Am J Obstet Gynecol; 2005 Jul; 193(1):76-82. PubMed ID: 16021062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.